rxstat › Shortages › Meloxicam
Meloxicam shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Meloxicam products are in shortage in Canada (3 of 18 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 10, 2026.
In shortage since
Jan 8, 2020
Est. full return
Jul 10, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · since Apr 28, 2026, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortageAPO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · since Feb 4, 2025, est. end Mar 27, 2026 · Disruption of the manufacture of the drug.
Active shortageTEVA-MELOXICAM
7.5MG · TABLET · TEVA CANADA LIMITED
DIN 02258315 · since Mar 10, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortageACT MELOXICAM
7.5MG · TABLET · TEVA CANADA LIMITED
DIN 02250012 · since Jan 8, 2020, no end estimate · Disruption of the manufacture of the drug.
ResolvedAPO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · ended Apr 9, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-MELOXICAM
15MG · TABLET · TEVA CANADA LIMITED
DIN 02258323 · ended Nov 19, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · ended Sep 18, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · ended Sep 11, 2025 · Disruption of the manufacture of the drug.
ResolvedAURO-MELOXICAM
7.5MG · TABLET · AURO PHARMA INC
DIN 02390884 · ended Jul 24, 2025 · Demand increase for the drug.
ResolvedAPO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · ended Jul 10, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · ended Mar 20, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-MELOXICAM
1.5G · SUSPENSION · APOTEX INC
DIN 02396467 · ended Mar 6, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Meloxicam is currently affected by 3 active shortage reports filed with Health Canada by APOTEX INC, TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Recent changes
Common questions
When will Meloxicam be back in stock in Canada?
The latest manufacturer estimate is Jul 10, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Meloxicam in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.